Literature DB >> 21160598

Computed tomography overestimation of esophageal tumor length: Implications for radiotherapy planning.

Karim Sillah1, Luke R Williams, Hans-Ulrich Laasch, Azeem Saleem, Gillian Watkins, Susan A Pritchard, Patricia M Price, Catharine M West, Ian M Welch.   

Abstract

AIM: To assess the relationship between preoperative computed tomography (CT) and postoperative pathological measurements of esophageal tumor length and the prognostic significance of CT tumor length data.
METHODS: A retrospective study was carried out in 56 patients who underwent curative esophagogastrectomy. Tumor lengths were measured on the immediate preoperative CT and on the post-operative resection specimens. Inter- and intra-observer variations in CT measurements were assessed. Survival data were collected.
RESULTS: There was a weak correlation between CT and pathological tumor length (r = 0.30, P = 0.025). CT lengths were longer than pathological lengths in 68% (38/56) of patients with a mean difference of 1.67 cm (95% CI: 1.18-2.97). The mean difference in measurements by two radiologists was 0.39 cm (95% CI: -0.59-1.44). The mean difference between repeat CT measured tumor length (intra-observer variation) were 0.04 cm (95% CI: -0.59-0.66) and 0.47 cm (95% CI: -0.53-1.47). When stratified, patients not receiving neoadjuvant chemotherapy showed a strong correlation between CT and pathological tumor length (r = 0.69, P = 0.0014, n = 37) than patients that did (r = 0.13, P = 0.43, n = 19). Median survival with CT tumor length > 5.6 cm was poorer than with smaller tumors, but the difference was not statistically significant.
CONCLUSION: Esophageal tumor length assessed using CT does not reflect pathological tumor extent and should not be the only modality used for management decisions, particularly for planning radiotherapy.

Entities:  

Keywords:  Computed tomography; Esophageal cancer; Radiotherapy

Year:  2010        PMID: 21160598      PMCID: PMC2999183          DOI: 10.4251/wjgo.v2.i4.197

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  36 in total

1.  Disparate surgical margin lengths of colorectal resection specimens between in vivo and in vitro measurements. The effects of surgical resection and formalin fixation on organ shrinkage.

Authors:  N S Goldstein; A Soman; J Sacksner
Journal:  Am J Clin Pathol       Date:  1999-03       Impact factor: 2.493

2.  Shrinkage of the esophagus after resection for carcinoma.

Authors:  K F Siu; H C Cheung; J Wong
Journal:  Ann Surg       Date:  1986-02       Impact factor: 12.969

3.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

Review 4.  Staging in oesophageal cancer.

Authors:  J Th M Plukker; H L van Westreenen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2006       Impact factor: 3.043

5.  Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography?

Authors:  Corrado Pedrazzani; Marco Bernini; Simone Giacopuzzi; Raffaele Pugliese; Filippo Catalano; Mara Festini; Luca Rodella; Giovanni de Manzoni
Journal:  J Surg Oncol       Date:  2005-09-15       Impact factor: 3.454

6.  Endoscopic ultrasonography for assessment of the response to combined radiation therapy and chemotherapy in patients with esophageal cancer.

Authors:  M Giovannini; J F Seitz; P Thomas; J M Hannoun-Levy; H Perrier; M Resbeut; J R Delpero; P Fuentes
Journal:  Endoscopy       Date:  1997-01       Impact factor: 10.093

7.  Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone.

Authors:  Hitoshi Ishikawa; Hideyuki Sakurai; Michitaka Yamakawa; Yoshihiro Saito; Yuko Nakayama; Yoshizumi Kitamoto; Masahiko Okamoto; Kousaku Harada; Masatoshi Hasegawa; Takashi Nakano
Journal:  J Clin Gastroenterol       Date:  2005-07       Impact factor: 3.062

8.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

9.  Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction.

Authors:  Kuai-le Zhao; Zhongxing Liao; M Kara Bucci; Ritsuko Komaki; James D Cox; Zhiqian H Yu; Lifei Zhang; Radhe Mohan; Lei Dong
Journal:  Radiother Oncol       Date:  2007-08-22       Impact factor: 6.280

10.  Dosimetric consequences of breath-hold respiration in conformal radiotherapy of esophageal cancer.

Authors:  J L Dumas; A Noël; D Wolf; J F Bosset; P Aletti
Journal:  Phys Med       Date:  2006 October - December       Impact factor: 2.685

View more
  13 in total

1.  Feasibility of a novel liquid fiducial marker for use in image guided radiotherapy of oesophageal cancer.

Authors:  Steen Riisgaard de Blanck; Jonas Scherman-Rydhög; Mette Siemsen; Merete Christensen; Lene Baeksgaard; Rasmus Irming Jølck; Lena Specht; Thomas Lars Andresen; Gitte Fredberg Persson
Journal:  Br J Radiol       Date:  2018-07-09       Impact factor: 3.039

2.  Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer.

Authors:  Mathieu Hatt; Dimitris Visvikis; Olivier Pradier; Catherine Cheze-le Rest
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

3.  Tumour size of resectable oesophageal squamous cell carcinoma measured with multidetector computed tomography for predicting regional lymph node metastasis and N stage.

Authors:  Hang Li; Tian-wu Chen; Zhen-lin Li; Xiao-ming Zhang; Xiao-li Chen; Li-ying Wang; Li Zhou; Rui Li; Chun-ping Li; Xiao-hua Huang
Journal:  Eur Radiol       Date:  2012-06-01       Impact factor: 5.315

4.  Tumor Size as a Critical Prognostic Factor in T1-2 Stage Esophageal Cancer.

Authors:  Zilong Wu; Bentong Yu
Journal:  Gastroenterol Res Pract       Date:  2020-08-17       Impact factor: 2.260

Review 5.  Imaging strategies in the management of oesophageal cancer: what's the role of MRI?

Authors:  Peter S N van Rossum; Richard van Hillegersberg; Frederiek M Lever; Irene M Lips; Astrid L H M W van Lier; Gert J Meijer; Maarten S van Leeuwen; Marco van Vulpen; Jelle P Ruurda
Journal:  Eur Radiol       Date:  2013-02-13       Impact factor: 5.315

6.  Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma.

Authors:  Dong-Liang Hou; Gao-Feng Shi; Xian-Shu Gao; Junichi Asaumi; Xue-Ying Li; Hui Liu; Chen Yao; Joe Y Chang
Journal:  Radiat Oncol       Date:  2013-07-06       Impact factor: 3.481

7.  Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancer.

Authors:  Yanluan Guo; Jianbin Li; Peng Zhang; Qian Shao; Min Xu; Yankang Li
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

8.  DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer.

Authors:  S Münch; M Oechsner; S E Combs; D Habermehl
Journal:  Radiat Oncol       Date:  2017-08-15       Impact factor: 3.481

9.  Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study.

Authors:  M E Nowee; F E M Voncken; A N T J Kotte; L Goense; P S N van Rossum; A L H M W van Lier; S W Heijmink; B M P Aleman; J Nijkamp; G J Meijer; I M Lips
Journal:  Clin Transl Radiat Oncol       Date:  2018-10-26

10.  Comparison of gross target volumes based on four-dimensional CT, positron emission tomography-computed tomography, and magnetic resonance imaging in thoracic esophageal cancer.

Authors:  Huimin Li; Fengxiang Li; Jianbin Li; Youzhe Zhu; Yingjie Zhang; Yanluan Guo; Min Xu; Qian Shao; Xijun Liu
Journal:  Cancer Med       Date:  2020-06-08       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.